1. Home
  2. USA vs NKTR Comparison

USA vs NKTR Comparison

Compare USA & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty All-Star Equity Fund

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$6.08

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$74.93

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USA
NKTR
Founded
N/A
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
USA
NKTR
Price
$6.08
$74.93
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$146.67
AVG Volume (30 Days)
1.5M
645.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$5.40
$23.68
52 Week High
$6.65
$109.00

Technical Indicators

Market Signals
Indicator
USA
NKTR
Relative Strength Index (RSI) 69.35 61.25
Support Level $5.66 $64.99
Resistance Level $6.09 $75.82
Average True Range (ATR) 0.07 2.91
MACD 0.03 0.41
Stochastic Oscillator 98.96 78.51

Price Performance

Historical Comparison
USA
NKTR

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a diversified, closed-end management investment company. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: